PTC Therapeutics, Inc. (PTCT)

72.43 +0.73 (+1.02%) USD  |  NASDAQ  |  Apr 17, 16:00
72.41 -0.02 (-0.03%) Pre-Market: 20:00
More

PTC Therapeutics Total Operating Expenses (% of Quarterly Revenues)

Total Operating Expenses (% of Quarterly Revenues) Chart

View Total Operating Expenses (% of Quarterly Revenues) for PTCT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Operating Expenses (% of Quarterly Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Operating Expenses (% of Quarterly Revenues) Range, Past 5 Years

View Total Operating Expenses (% of Quarterly Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Operating Expenses (% of Quarterly Revenues) Benchmarks

View Total Operating Expenses (% of Quarterly Revenues) Benchmarks
Start Trial
Insmed, Inc. Upgrade
Sarepta Therapeutics, Inc. Upgrade
Keros Therapeutics, Inc. Upgrade
Madrigal Pharmaceuticals, Inc. Upgrade
Protagonist Therapeutics, Inc. Upgrade